Trump administration sues California over cage-free egg and animal welfare laws
'California has contributed to the historic rise in egg prices by imposing unnecessary red tape on the production of eggs,' wrote lawyers in the lawsuit, which was filed in U.S. District Court in Los Angeles Wednesday.
California Gov. Gavin Newsom and Attorney General Rob Bonta vowed to defend the state law.
'Pointing fingers won't change the fact that it is the President's economic policies that have been destructive. We'll see him in court,' Bonta said in a statement.
California's animal-welfare law was approved by voters as Proposition 12 in 2018. The law was upheld by the U.S. Supreme Court in 2023.
'In a functioning democracy, policy choices like these usually belong to the people and their elected representatives,' wrote Justice Neil Gorsuch, a Trump appointee, in the lead opinion. He said that while many state laws may have economic effects in other states, they are only in violation of the Constitution if they were written with the intent to interfere with interstate commerce.
The Department of Justice contends the California law preempts federal laws, including the Egg Products Inspection Act, and that no state has the right to institute its own standards on the production or 'quality, condition, weight, quantity or grade' of eggs that differs from those set by the federal government.
The law has been repeatedly challenged by the National Pork Producers Council and others. Just last month, the Supreme Court declined to accept a petition for certiorari from the Iowa Pork Producers Council.
In the suit filed Wednesday, the Justice Department contends that California's egg standards 'do not advance consumer welfare' and are 'not based in specific peer-reviewed published scientific literature or accepted as standards within the scientific community to reduce human food-borne illness . . . or other human or safety concerns.'
Egg prices soared earlier this year, soon after Trump took office. Most experts pointed to the H5N1 bird flu epidemic as the cause of the spike, as millions of egg-laying chickens across the nation were euthanized to prevent the spread.
Prices have since moderated as the outbreak has diminished. In the past 30 days, there has been only one reported commercial flock infection in Pennsylvania. The birds were not egg layers.
In February, the US Department of Agriculture's Secretary, Brooke Rollins, penned an op-ed in the Wall Street Journal suggesting the Trump Administration would target the law.
California egg producers have in the past opposed changing the law.
Bill Mattos, president of the California Poultry Federation, said in an interview in February that California egg farmers had spent millions of dollars to upgrade and adapt their farms. Reversing the law would put California poultry farmers — and all the other egg producers that sell to California — at a huge economic disadvantage by requiring them to invest millions more dollars to buy cages and re-adapt their facilities for such operations.
Animal welfare advocates say the lawsuit is short-sighted and has the potential to hurt California's egg laying industry.
'With this ill-considered legal action, the Administration is dropping a set of stink bombs into the bosom of the egg industry,' said Wayne Pacelle, president of Animal Wellness Action and the Center for a Humane Economy.
He said California egg farmers are still recovering from the bird flu outbreak, and this suit, if successful, would disrupt the still fragile supply chain 'and provide an opening for egg farmers from Mexico – which have no animal welfare standards at all—to access the California market.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
an hour ago
- Boston Globe
MAGA comes for one of its own: Pam Bondi
That has parts of MAGA world, which has been obsessed with Epstein since he died by suicide in a New York jail while awaiting trial on federal child sex trafficking charges in 2019, in a twist. 'This is Jeffrey Epstein; this is the most famous pedophile in modern-day history,' Republican Representative Marjorie Taylor Greene of Georgia said during an Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up Greene said that Ghislaine Maxwell, a close Epstein confidante convicted of federal child sex trafficking charges and sentenced to 20 years in prison, had 'a little black book' of more than 2,000 names, including 'famous celebrities, world leaders, foreign leaders, and very rich businessmen.' Advertisement Among Epstein's high-profile friends were Prince Andrew, Bill Clinton, and Trump, who once called the mysterious and mysteriously wealthy man with a private island Advertisement From Vice President But some, like far-right extremist For years, right-wing conspiracy theorists have claimed that Epstein was murdered in his jail cell to protect the identities of those who may have been blackmailed by him. Now far-right figures ranging from Before he was reelected, Trump was asked during a While Trump said that he would do so, he also hedged, claiming that he would be wary because 'you don't want to affect people's lives if it's phony stuff in there 'cause it's a lot of phony stuff with that whole world.' (He didn't elaborate.) But he added that it would be 'interesting' to find out more about Epstein's death, which he called 'a weird situation.' Advertisement The joint DOJ/FBI memo confirmed that Epstein died by suicide. Now, neither Trump nor anyone in his administration wants to talk about the alleged Epstein client list that was before it wasn't. At a recent Cabinet meeting, he 'I mean, I can't believe you're asking a question on Epstein at a time like this, where we're having some of the greatest success and also tragedy with what happened in Texas,' the president said, referring to the catastrophic flash floods that have killed at least 120 people. 'It just seems like a desecration.' As much as Trump wants this subject buried, not all of MAGA is ready to let this go away quietly. This even led to the odd sight of Karoline Leavitt, Trump's press secretary, being From the attorney general's neglect of due process for immigrants being snatched from communities nationwide to her willingness to Renée Graham is a Globe columnist. She can be reached at
CNBC
2 hours ago
- CNBC
Global week ahead: Trade tensions cloud earnings and the G20 heads south
Earnings season always seems to roll around with alarming frequency. The newsroom approaches each quarter with a nervous energy, but this summer it feels especially heightened. Recent market records in both the U.S. and Europe, alongside an unpredictable economic environment, paint a complicated picture for the second half. It all kicks off on Tuesday with America's banking behemoths, as attention switches from the White House back to Wall Street. But U.S. President Donald Trump's policies still loom large, with Goldman Sachs predicting that, this quarter, U.S. earnings will start to show the impact of the tariffs. The investment bank's economists see "conflicting messages on the margin outlook" as companies have only announced modest price increases, despite the cost hikes associated with higher tariffs. Earnings-per-share growth is also set to come under pressure, with Goldman suggesting, "the consensus estimate among analysts sees S&P 500 companies' earnings-per-share growth decelerating to 4% this quarter relative to the same quarter last year — down from 12% in the first quarter." With the banks set to dominate next week — JPMorgan, Citi, Goldman Sachs, Morgan Stanley and Bank of America are all reporting within just two days — maybe Europe can provide some optimism. As reported by CNBC's Jenni Reid, European banks just recorded their best first half since 1997. Gains were driven by strong investment banking returns — something their U.S. counterparts are also likely to capitalize on — as well as stock rallies based on both deal speculation and actual M&A. As someone who grew up in Cape Town, seeing this year's G20 meetings take place in South Africa makes me pine for the sunshine of the Southern hemisphere. Next week's meeting in Durban between finance ministers and central bank governors comes at an interesting time for the country. An Oval Office meeting between South African President Cyril Ramaphosa and Trump went spectacularly wrong back in May, when the latter, flanked by his South African (now former) right-hand man Elon Musk, made false claims of a "white genocide." It seems tensions have not abated. U.S. Treasury Secretary Scott Bessent will skip the meeting altogether, opting to head to Japan instead, according to Reuters. South Africa is also subject to a new 30% tariff rate, the only country in sub-Saharan Africa to be singled out in the latest round of announcements. It does not bode well for the G20 Leaders meeting, due to be held in Gauteng on Nov. 22-23. It remains to be seen if Trump will attend. In May, South Africa's golfing greats — who traveled to the White House with Ramaphosa — failed to win over Trump. But maybe the lure of some of the best courses in the world, along with a South African summer, could see a seasonal change in his mood toward the country later this year.
Boston Globe
2 hours ago
- Boston Globe
US aid cuts halt HIV vaccine research in South Africa, with global impact
But the $46 million from the U.S. for the project was disappearing, part of the dismantling of foreign aid by the world's biggest donor earlier this year as President Donald Trump announced a focus on priorities at home. Advertisement South Africa hit hard by aid cuts South Africa has been hit especially hard because of Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused PEPFAR. Now that's gone. Glenda Grey, who heads the Brilliant program, said the African continent has been vital to the development of HIV medication, and the U.S. cuts threaten its capability to do such work in the future. Significant advances have included clinical trials for lenacapavir, the world's only twice-a-year shot to prevent HIV, recently approved for use by the U.S. Food and Drug Administration. One study to show its efficacy involved young South Africans. 'We do the trials better, faster and cheaper than anywhere else in the world, and so without South Africa as part of these programs, the world, in my opinion, is much poorer,' Gray said. Advertisement She noted that during the urgency of the COVID-19 pandemic, South Africa played a crucial role by testing the Johnson & Johnson and Novavax vaccines, and South African scientists' genomic surveillance led to the identification of an important variant. Labs empty and thousands are laid off A team of researchers at the University of the Witwatersrand has been part of the unit developing the HIV vaccines for the trials. Inside the Wits laboratory, technician Nozipho Mlotshwa was among the young people in white gowns working on samples, but she may soon be out of a job. Her position is grant-funded. She uses her salary to support her family and fund her studies in a country where youth unemployment hovers around 46%. 'It's very sad and devastating, honestly,' she said of the U.S. cuts and overall uncertainty. 'We'll also miss out collaborating with other scientists across the continent.' Professor Abdullah Ely leads the team of researchers. He said the work had promising results indicating that the vaccines were producing an immune response. But now that momentum, he said, has 'all kind of had to come to a halt.' The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped. South Africa's health department says about 100 researchers for that program and others related to HIV have been laid off. Funding for postdoctoral students involved in experiments for the projects is at risk. South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research funding over the next five years due to the aid cuts, which affect not only work on HIV but also tuberculosis — another disease with a high number of cases in the country. Advertisement Less money, and less data on what's affected South Africa's government has said it will be very difficult to find funding to replace the U.S. support. And now the number of HIV infections will grow. Medication is more difficult to obtain. At least 8,000 health workers in South Africa's HIV program have already been laid off, the government has said. Also gone are the data collectors who tracked patients and their care, as well as HIV counselors who could reach vulnerable patients in rural communities. For researchers, Universities South Africa, an umbrella body, has applied to the national treasury for over $110 million for projects at some of the largest schools. During a visit to South Africa in June, UNAIDS executive director Winnie Byanyima was well aware of the stakes, and the lives at risk, as research and health care struggle in South Africa and across Africa at large. Other countries that were highly dependent on U.S. funding including Zambia, Nigeria, Burundi and Ivory Coast are already increasing their own resources, she said. 'But let's be clear, what they are putting down will not be funding in the same way that the American resources were funding,' Byanyima said. Associated Press writer Michelle Gumede in Johannesburg contributed to this report.
